Estuary Biotherapeutics launches to treat kidney disease with gene therapies
Estuary Biotherapeutics launched to develop gene therapies for kidney disease, founded by ex-MyoKardia CEO Wayne Sackett. The company plans to translate research showing reactivating Pkd genes can rev
cen · 2026-10-16 00:00 UTC